WHO ICTRP trial
to check the Effect and Safety of Nuvastatic in Reducing Cancer Related Fatigue…
CTRI/2025/05/087937 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2025/05/087937 |
|---|---|
| Public title | to check the Effect and Safety of Nuvastatic in Reducing Cancer Related Fatigue in Colon Cancer Patients |
| Scientific title | Phase III Randomized Double Blind Placebo Controlled Study to Evaluate the Efficacy and Safety of Nuvastatic in Reducing Cancer Related Fatigue in Colon Cancer Patients Undergoing First Line Chemotherapy - NIL |
| Primary sponsor | Natureceuticals Sdn Bhd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: C189- Malignant neoplasm of colon, unspecified |
| Interventions | Intervention1: Nuvastatic 1000mg Sachet: Nuvastatic 1000mg Sachets to be consumed after meal 1 Sachet 3 times a day to be consumed for 3 cycles(Eah cycle 21 days) to be taken with water as suggested by Principal investigator Control… |
| Registration date | May 30, 2025 |
| Target size | 180 |
| Secondary IDs | NUVA-CC-III-2025 1.0 Dated 07/MAY/2025 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: